Bank of America’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-459
| Closed | -$1.68K | – | 6107 |
|
|
2025
Q4 | $1.68K | Sell |
459
-6,663
| -94% | -$19K | ﹤0.01% | 6423 |
|
|
2025
Q3 | $26.3K | Buy |
7,122
+6,426
| +923% | +$16.2K | ﹤0.01% | 7011 |
|
|
2025
Q2 | $1.29K | Buy |
696
+37
| +6% | +$64 | ﹤0.01% | 7487 |
|
|
2025
Q1 | $1.03K | Buy |
659
+53
| +9% | +$93 | ﹤0.01% | 7417 |
|
|
2024
Q4 | $1.23K | Sell |
606
-303
| -33% | -$549 | ﹤0.01% | 7257 |
|
|
2024
Q3 | $1.31K | Buy |
909
+27
| +3% | +$51 | ﹤0.01% | 7196 |
|
|
2024
Q2 | $1.51K | Buy |
882
+111
| +14% | +$201 | ﹤0.01% | 7179 |
|
|
2024
Q1 | $1.54K | Sell |
771
-14
| -2% | -$28 | ﹤0.01% | 7156 |
|
|
2023
Q4 | $2.36K | Sell |
785
-189
| -19% | -$500 | ﹤0.01% | 7115 |
|
|
2023
Q3 | $4.24K | Buy |
974
+33
| +4% | +$226 | ﹤0.01% | 7029 |
|
|
2023
Q2 | $7.76K | Sell |
941
-114
| -11% | -$1.13K | ﹤0.01% | 6920 |
|
|
2023
Q1 | $13K | Sell |
1,055
-1,423
| -57% | -$16.9K | ﹤0.01% | 6869 |
|
|
2022
Q4 | $24.3K | Buy |
2,478
+427
| +21% | +$4.73K | ﹤0.01% | 6678 |
|
|
2022
Q3 | $26K | Buy |
2,051
+1,529
| +293% | +$22.9K | ﹤0.01% | 6935 |
|
|
2022
Q2 | $7K | Sell |
522
-165
| -24% | -$2.44K | ﹤0.01% | 7501 |
|
|
2022
Q1 | $14K | Sell |
687
-7,990
| -92% | -$219K | ﹤0.01% | 7641 |
|
|
2021
Q4 | $326K | Buy |
8,677
+1,453
| +20% | +$64.8K | ﹤0.01% | 6188 |
|
|
2021
Q3 | $349K | Buy |
7,224
+135
| +2% | +$6.59K | ﹤0.01% | 5903 |
|
|
2021
Q2 | $379K | Buy |
7,089
+3,582
| +102% | +$216K | ﹤0.01% | 5637 |
|
|
2021
Q1 | $185K | Buy |
3,507
+2,023
| +136% | +$114K | ﹤0.01% | 6092 |
|
|
2020
Q4 | $70K | Buy |
1,484
+80
| +6% | +$3.46K | ﹤0.01% | 6159 |
|
|
2020
Q3 | $85K | Sell |
1,404
-1,688
| -55% | -$86K | ﹤0.01% | 5779 |
|
|
2020
Q2 | $124K | Sell |
3,092
-533
| -15% | -$19.8K | ﹤0.01% | 5562 |
|
|
2020
Q1 | $103K | Buy |
3,625
+3,078
| +563% | +$102K | ﹤0.01% | 5514 |
|
|
2019
Q4 | $21K | Hold |
547
| – | – | ﹤0.01% | 6494 |
|
|
2019
Q3 | $12K | Sell |
547
-1,819
| -77% | -$42.8K | ﹤0.01% | 6683 |
|
|
2019
Q2 | $54K | Buy |
2,366
+1,773
| +299% | +$45.6K | ﹤0.01% | 6273 |
|
|
2019
Q1 | $15K | Sell |
593
-530
| -47% | -$13.9K | ﹤0.01% | 6557 |
|
|
2018
Q4 | $15K | Buy |
1,123
+769
| +217% | +$12.8K | ﹤0.01% | 6550 |
|
|
2018
Q3 | $8K | Sell |
354
-216
| -38% | -$6.91K | ﹤0.01% | 6723 |
|
|
2018
Q2 | $25K | Sell |
570
-157
| -22% | -$8.84K | ﹤0.01% | 6431 |
|
|
2018
Q1 | $49K | Sell |
727
-94
| -11% | -$5.95K | ﹤0.01% | 6047 |
|
|
2017
Q4 | $49K | Buy |
821
+107
| +15% | +$6.3K | ﹤0.01% | 6078 |
|
|
2017
Q3 | $47K | Buy |
714
+270
| +61% | +$18.2K | ﹤0.01% | 5970 |
|
|
2017
Q2 | $32K | Sell |
444
-19
| -4% | -$1.12K | ﹤0.01% | 6054 |
|
|
2017
Q1 | $25K | Buy |
463
+91
| +24% | +$4.07K | ﹤0.01% | 6224 |
|
|
2016
Q4 | $15K | Buy |
372
+137
| +58% | +$5.12K | ﹤0.01% | 6444 |
|
|
2016
Q3 | $11K | Sell |
235
-343
| -59% | -$14.6K | ﹤0.01% | 6350 |
|
|
2016
Q2 | $23K | Buy |
578
+491
| +564% | +$22.9K | ﹤0.01% | 6179 |
|
|
2016
Q1 | $4K | Hold |
87
| – | – | ﹤0.01% | 6630 |
|
|
2015
Q4 | $4K | Sell |
87
-200
| -70% | -$8.38K | ﹤0.01% | 6938 |
|
|
2015
Q3 | $11K | Buy |
287
+147
| +105% | +$6.87K | ﹤0.01% | 6525 |
|
|
2015
Q2 | $7K | Sell |
140
-1,274
| -90% | -$65.4K | ﹤0.01% | 6704 |
|
|
2015
Q1 | $82K | Sell |
1,414
-5,439
| -79% | -$227K | ﹤0.01% | 5414 |
|
|
2014
Q4 | $251K | Sell |
6,853
-54
| -0.8% | -$1.59K | ﹤0.01% | 5189 |
|
|
2014
Q3 | $218K | Sell |
6,907
-7,082
| -51% | -$188K | ﹤0.01% | 5314 |
|
|
2014
Q2 | $361K | Buy |
13,989
+6,735
| +93% | +$178K | ﹤0.01% | 4942 |
|
|
2014
Q1 | $215K | Sell |
7,254
-648
| -8% | -$25.3K | ﹤0.01% | 5380 |
|
|
2013
Q4 | $312K | Sell |
7,902
-3,336
| -30% | -$129K | ﹤0.01% | 5188 |
|
|
2013
Q3 | $1.18M | Buy |
11,238
+6,599
| +142% | +$809K | ﹤0.01% | 3779 |
|
|
2013
Q2 | $598K | Buy |
+4,639
| New | +$684K | ﹤0.01% | 4577 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Bank of America's FBIO Position: Q1 2026 in Review
Bank of America sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 459 shares — an estimated $1.68K sold.
Bank of America first reported a position in FBIO in Q2 2013 and held it in 51 quarters. The position peaked at $1.18M in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Bank of America reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 459 Fortress Biotech shares in Q1 2026, an estimated $1.68K.
- Bank of America first reported a position in Fortress Biotech in Q2 2013 and held it in 51 quarters.
- Bank of America's Fortress Biotech position peaked at $1.18M in Q3 2013.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.